Aripiprazole

2 Drugs classified under this active ingredient

Atypical Antipsychotic. Aripiprazole (as monohydrate) 300 mg, 400 mg.
PRE-FILLED SYR. (pwdr.+ solvent for prolong. -release susp.): 1,3. Recom. init. & mainten. dose: 400 mg. once mnthly. as a single inj. (no sooner than 26 d after the previous inj.). After the 1^st inj., tmt. with 10 mg-20 mg oral aripiprazole should be cont. for 14 consec. days to maintain therapeutic aripiprazole concent. during init. of ther. See lit.
Maintenan. tmt. of schizophrenia in adult pts. stabilised with oral aripiprazole.
C/I: Hypersens.

Atypical Antipsychotic. Aripiprazole 5, 10, 15, 30 mg.
TABS: 28 x 5 mg, 10 mg, 15 mg, 30
mg.
Take whole w/out meals. Schizophren:
Adult >18 yrs: 10-15 mg dly. Maint. 15
mg dly, max. 30 mg dly. Adolescents
(15 yrs and older): recommend. dose
10 mg dly. Max. dly dose: 30 mg.
Mania: Adult >18 yrs: 15 mg daily, incr.
if necess. to 30 mg dly. Not to exceed
recomm. dose. Irritability
Assoc. with Autistic Dis. (6-17 yrs):
initiate at 2.5 mg/d, dose range 5 – 15
mg dly. See lit.
Tmt. of schizophrenia, tmt. of mod.- severe
manic epis. in Bipolar I disord., prevent. of
a new manic epis. in pts who experienced
predomin. manic epis. whose manic
epis. respond. to aripiprazole tmt. Use as
an adjunct. ther. to antidepress. for tmt. of
major depress. dis. (MDD). Efficacy was
establ. in two 6-week trials in adults with
MDD who had an inadeq. resp. to
antidepr. ther. during the curr. epis. Tmt. of
irritability assoc. with autistic dis. Efficacy
was establ. in two 8-week trials in ped. pts
(aged 6 - 17 yrs) with irritab. assoc. with
autistic dis. (incl. sympt. of aggress.
towards others, delib. self-inj., temper
tantrums, quickly chang. moods).
C/I: Hypersens.